These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 29133343)

  • 1. Clinical and Histologic Characterization of Nonalcoholic Steatohepatitis in African American Patients.
    Bril F; Portillo-Sanchez P; Liu IC; Kalavalapalli S; Dayton K; Cusi K
    Diabetes Care; 2018 Jan; 41(1):187-192. PubMed ID: 29133343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes.
    Lomonaco R; Bril F; Portillo-Sanchez P; Ortiz-Lopez C; Orsak B; Biernacki D; Lo M; Suman A; Weber MH; Cusi K
    Diabetes Care; 2016 Apr; 39(4):632-8. PubMed ID: 26861926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
    Portillo Sanchez P; Bril F; Maximos M; Lomonaco R; Biernacki D; Orsak B; Subbarayan S; Webb A; Hecht J; Cusi K
    J Clin Endocrinol Metab; 2014 Oct; 100(5):. PubMed ID: 25303488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.
    Bian H; Zhu X; Xia M; Yan H; Chang X; Hu X; Pan B; Guo W; Li X; Gao X
    Endocr Pract; 2020 Apr; 26(4):444-453. PubMed ID: 31968197
    [No Abstract]   [Full Text] [Related]  

  • 5. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
    Portillo-Sanchez P; Bril F; Maximos M; Lomonaco R; Biernacki D; Orsak B; Subbarayan S; Webb A; Hecht J; Cusi K
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2231-8. PubMed ID: 25885947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Fibroblast Growth Factor 21 Is Associated With Severity of Nonalcoholic Steatohepatitis in Patients With Obesity and Type 2 Diabetes.
    Barb D; Bril F; Kalavalapalli S; Cusi K
    J Clin Endocrinol Metab; 2019 Aug; 104(8):3327-3336. PubMed ID: 30848827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.
    Meis SB; Schuster D; Gaillard T; Osei K
    Ethn Dis; 2006; 16(4):830-6. PubMed ID: 17061734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein Profiles in Class III Obese Caucasian and African American Women with Nonalcoholic Fatty Liver Disease.
    Garcia AE; Kasim N; Tamboli RA; Gonzalez RS; Antoun J; Eckert EA; Marks-Shulman PA; Dunn J; Wattacheril J; Wallen T; Abumrad NN; Flynn CR
    PLoS One; 2015; 10(11):e0142676. PubMed ID: 26599819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.
    Maximos M; Bril F; Portillo Sanchez P; Lomonaco R; Orsak B; Biernacki D; Suman A; Weber M; Cusi K
    Hepatology; 2015 Jan; 61(1):153-60. PubMed ID: 25145475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.
    Williams CD; Stengel J; Asike MI; Torres DM; Shaw J; Contreras M; Landt CL; Harrison SA
    Gastroenterology; 2011 Jan; 140(1):124-31. PubMed ID: 20858492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic markers, regional adiposity, and adipose cell size: relationship to insulin resistance in African-American as compared with Caucasian women.
    Allister-Price C; Craig CM; Spielman D; Cushman SS; McLaughlin TL
    Int J Obes (Lond); 2019 Jun; 43(6):1164-1173. PubMed ID: 30127463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. African Americans have a distinct clinical and histologic profile with lower prevalence of NASH and advanced fibrosis relative to Caucasians.
    Satapathy SK; Marella HK; Heda RP; Ganguli S; Kirthi Reddy Y; Podila PSB; Clark I; Maliakkal B
    Eur J Gastroenterol Hepatol; 2021 Mar; 33(3):388-398. PubMed ID: 32317586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipose Tissue Insulin Resistance Predicts the Severity of Liver Fibrosis in Patients With Type 2 Diabetes and NAFLD.
    Kalavalapalli S; Leiva EG; Lomonaco R; Chi X; Shrestha S; Dillard R; Budd J; Romero JP; Li C; Bril F; Samraj G; Pennington J; Townsend P; Orlando F; Shetty S; Mansour L; Silva-Sombra LR; Bedossa P; Malaty J; Barb D; Gurka MJ; Cusi K
    J Clin Endocrinol Metab; 2023 Apr; 108(5):1192-1201. PubMed ID: 36378995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 2 Diabetes Mellitus and Simple Glucose Metabolism Parameters may Reliably Predict Nonalcoholic Fatty Liver Disease Features.
    Cazzo E; Jimenez LS; Gestic MA; Utrini MP; Chaim FHM; Chaim FDM; Pareja JC; Chaim EA
    Obes Surg; 2018 Jan; 28(1):187-194. PubMed ID: 28741239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease.
    Nascimbeni F; Bedossa P; Fedchuk L; Pais R; Charlotte F; Lebray P; Poynard T; Ratziu V;
    J Hepatol; 2020 May; 72(5):828-838. PubMed ID: 31862486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease.
    Bril F; Barb D; Portillo-Sanchez P; Biernacki D; Lomonaco R; Suman A; Weber MH; Budd JT; Lupi ME; Cusi K
    Hepatology; 2017 Apr; 65(4):1132-1144. PubMed ID: 27981615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of serum retinoic acid with hepatic steatosis and liver injury in nonalcoholic fatty liver disease.
    Liu Y; Chen H; Wang J; Zhou W; Sun R; Xia M
    Am J Clin Nutr; 2015 Jul; 102(1):130-7. PubMed ID: 25948673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS).
    Hossain N; Stepanova M; Afendy A; Nader F; Younossi Y; Rafiq N; Goodman Z; Younossi ZM
    Scand J Gastroenterol; 2011 Apr; 46(4):479-84. PubMed ID: 21114431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher non-HDL-cholesterol to HDL-cholesterol ratio linked with increased nonalcoholic steatohepatitis.
    Wang D; Wang L; Wang Z; Chen S; Ni Y; Jiang D
    Lipids Health Dis; 2018 Apr; 17(1):67. PubMed ID: 29615042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severity of non-alcoholic steatohepatitis is not linked to testosterone concentration in patients with type 2 diabetes.
    Dayton KA; Bril F; Barb D; Lai J; Kalavalapalli S; Cusi K
    PLoS One; 2021; 16(6):e0251449. PubMed ID: 34077443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.